Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Scientific Reports|February 12, 2021
Optogenetic stimulation of cholinergic fibers for the modulation of insulin and glycemiaArjun K Fontaine, David G Ramirez, Samuel F Littich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Structurally distinct membrane nanotubes between human macrophages support long-distance vesicular traffic or surfing of bacteriaBjörn Onfelt, Shlomo Nedvetzki, Richard K P Benninger, et al.
NPJ Digital Medicine|April 6, 2026
Towards a physics informed digital twin to predict cerebral blood flow and cerebral vascular regulationJennifer K Briggs, J N Stroh, Soojin Park, et al.
Biophysical Journal|January 27, 2009
Live cell linear dichroism imaging reveals extensive membrane ruffling within the docking structure of natural killer cell immune synapsesRichard K P Benninger, Bruno Vanherberghen, Stephen Young, et al.
Diabetes|July 13, 2010
Gαo represses insulin secretion by reducing vesicular docking in pancreatic beta-cellsAizhen Zhao, Mica Ohara-Imaizumi, Marcella Brissova, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 19, 2014
Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertensionEva Nozik-Grayck, Crystal Woods, Joann M Taylor, et al.
Molecular Metabolism|November 8, 2022
Zinc transporter 8 haploinsufficiency protects against beta cell dysfunction in type 1 diabetes by increasing mitochondrial respirationYong Kyung Kim, Jay A Walters, Nicole D Moss, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Heterogeneous Kinetics of Nanobubble Ultrasound Contrast Agent and Angiogenic Signaling in Head and Neck CancerBenjamin Van Court, Mark Ciccaglione, Brooke Neupert, et al.
The Journal of Physiology|August 14, 2023
Restoring connexin-36 function in diabetogenic environments precludes mouse and human islet dysfunctionJoshua R St Clair, Matthew J Westacott, Jose Miranda, et al.
Theranostics|June 5, 2026
Submicron-sized ultrasound contrast agents as therapeutic peptide delivery vehicles in type 1 diabetesMark Ciccaglione, Eric Abenojar, Theresa Kosmides, et al.
Pageof 8